Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Comparable autoantibody serum levels against amyloid- and inflammation-associated proteins in Parkinson's disease patients and controls.

Maetzler W, Apel A, Langkamp M, Deuschle C, Dilger SS, Stirnkorb JG, Schulte C, Schleicher E, Gasser T, Berg D.

PLoS One. 2014 Feb 21;9(2):e88604. doi: 10.1371/journal.pone.0088604. eCollection 2014.

2.

Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.

Maetzler W, Berg D, Synofzik M, Brockmann K, Godau J, Melms A, Gasser T, Hörnig S, Langkamp M.

J Alzheimers Dis. 2011;26(1):171-9. doi: 10.3233/JAD-2011-110221.

PMID:
21593566
3.

Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia.

Kronimus Y, Albus A, Balzer-Geldsetzer M, Straub S, Semler E, Otto M, Klotsche J, Dodel R; LANDSCAPE Consortium, Mengel D.

PLoS One. 2016 Nov 1;11(11):e0164953. doi: 10.1371/journal.pone.0164953. eCollection 2016.

4.

Naturally occurring alpha-synuclein autoantibodies in Parkinson's disease: sources of (error) variance in biomarker assays.

Heinzel S, Gold M, Deuschle C, Bernhard F, Maetzler W, Berg D, Dodel R.

PLoS One. 2014 Dec 3;9(12):e114566. doi: 10.1371/journal.pone.0114566. eCollection 2014.

5.

Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease.

Besong-Agbo D, Wolf E, Jessen F, Oechsner M, Hametner E, Poewe W, Reindl M, Oertel WH, Noelker C, Bacher M, Dodel R.

Neurology. 2013 Jan 8;80(2):169-75. doi: 10.1212/WNL.0b013e31827b90d1. Epub 2012 Dec 19.

PMID:
23255825
6.

Humoral response against glial derived antigens in Parkinson's disease.

Papuć E, Kurzepa J, Kurys-Denis E, Grabarska A, Krupski W, Rejdak K.

Neurosci Lett. 2014 Apr 30;566:77-81. doi: 10.1016/j.neulet.2014.02.043. Epub 2014 Mar 1.

PMID:
24594199
7.

Autoantibodies against myelin sheath and S100β are associated with cognitive dysfunction in patients with rheumatoid arthritis.

Baptista TSA, Petersen LE, Molina JK, de Nardi T, Wieck A, do Prado A, Piovesan DM, Keisermann M, Grassi-Oliveira R, Bauer ME.

Clin Rheumatol. 2017 Sep;36(9):1959-1968. doi: 10.1007/s10067-017-3724-4. Epub 2017 Jun 27.

PMID:
28656478
8.

Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.

Kettunen P, Larsson S, Holmgren S, Olsson S, Minthon L, Zetterberg H, Blennow K, Nilsson S, Sjölander A.

J Alzheimers Dis. 2015;44(4):1313-22. doi: 10.3233/JAD-142025.

PMID:
25420549
9.

Lowered serum amyloid-β1-42 autoantibodies in individuals with lifetime depression.

Maetzler W, Langkamp M, Lerche S, Godau J, Brockmann K, Gaenslen A, Huber H, Wurster I, Niebler R, Eschweiler GW, Berg D.

J Alzheimers Dis. 2012;32(1):95-100.

PMID:
22766733
10.

Immunochemical Detection of α-Synuclein Autoantibodies in Parkinson's Disease: Correlation between Plasma and Cerebrospinal Fluid Levels.

Horvath I, Iashchishyn IA, Forsgren L, Morozova-Roche LA.

ACS Chem Neurosci. 2017 Jun 21;8(6):1170-1176. doi: 10.1021/acschemneuro.7b00063. Epub 2017 Mar 10.

PMID:
28263550
11.

α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.

Yanamandra K, Gruden MA, Casaite V, Meskys R, Forsgren L, Morozova-Roche LA.

PLoS One. 2011 Apr 25;6(4):e18513. doi: 10.1371/journal.pone.0018513.

12.

Autoimmune antibody decline in Parkinson's disease and Multiple System Atrophy; a step towards immunotherapeutic strategies.

Brudek T, Winge K, Folke J, Christensen S, Fog K, Pakkenberg B, Pedersen LØ.

Mol Neurodegener. 2017 Jun 7;12(1):44. doi: 10.1186/s13024-017-0187-7.

13.

Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease.

Goris A, Williams-Gray CH, Clark GR, Foltynie T, Lewis SJ, Brown J, Ban M, Spillantini MG, Compston A, Burn DJ, Chinnery PF, Barker RA, Sawcer SJ.

Ann Neurol. 2007 Aug;62(2):145-53.

PMID:
17683088
14.

Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein.

Albus A, Gold M, Bach JP, Burg-Roderfeld M, Jördens M, Kirchhein Y, Kronimus Y, Mengel D, Zerr I, Dodel R.

PLoS One. 2018 Aug 29;13(8):e0202954. doi: 10.1371/journal.pone.0202954. eCollection 2018.

15.

SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study.

Wider C, Vilariño-Güell C, Heckman MG, Jasinska-Myga B, Ortolaza-Soto AI, Diehl NN, Crook JE, Cobb SA, Bacon JA, Aasly JO, Gibson JM, Lynch T, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA.

Eur J Neurol. 2011 Jun;18(6):876-81. doi: 10.1111/j.1468-1331.2010.03297.x. Epub 2010 Dec 15.

PMID:
21159074
16.

Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia.

Maetzler W, Tian Y, Baur SM, Gauger T, Odoj B, Schmid B, Schulte C, Deuschle C, Heck S, Apel A, Melms A, Gasser T, Berg D.

PLoS One. 2012;7(10):e48042. doi: 10.1371/journal.pone.0048042. Epub 2012 Oct 25.

17.

Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.

Muntané G, Dalfó E, Martinez A, Ferrer I.

Neuroscience. 2008 Apr 9;152(4):913-23. doi: 10.1016/j.neuroscience.2008.01.030. Epub 2008 Feb 5.

PMID:
18343584
18.

Correlation between protective immunity to α-synuclein aggregates, oxidative stress and inflammation.

Gruden MA, Yanamandra K, Kucheryanu VG, Bocharova OR, Sherstnev VV, Morozova-Roche LA, Sewell RD.

Neuroimmunomodulation. 2012;19(6):334-42. doi: 10.1159/000341400. Epub 2012 Sep 11.

19.

Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.

Hall S, Öhrfelt A, Constantinescu R, Andreasson U, Surova Y, Bostrom F, Nilsson C, Håkan W, Decraemer H, Någga K, Minthon L, Londos E, Vanmechelen E, Holmberg B, Zetterberg H, Blennow K, Hansson O.

Arch Neurol. 2012 Nov;69(11):1445-52.

PMID:
22925882
20.

Supplemental Content

Support Center